Pulse Biosciences (PLSE) Equity Ratio (2015 - 2025)

Pulse Biosciences' Equity Ratio history runs 11 years deep, the most recent figure standing at 0.85 for Q4 2025.

• In Q4 2025, Equity Ratio fell 1.61% year-over-year to 0.85; the TTM figure through Dec 2025 stood at 0.85 (down 1.61% YoY), while the FY2025 annual figure was 0.85, down 1.61% from the prior year.
• Equity Ratio was 0.85 for Q4 2025 at Pulse Biosciences, roughly flat from 0.85 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.89 in Q1 2025 to a low of 0.15 in Q1 2023.
• Historically, Equity Ratio has averaged 0.62 across 5 years, with a median of 0.75 in 2021.
• Biggest YoY gain for Equity Ratio was 2697.89% in 2023; the steepest drop was 128.88% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.75 in 2021, then slumped by 103.85% to 0.03 in 2022, then soared by 2697.89% to 0.75 in 2023, then gained by 15.63% to 0.87 in 2024, then declined by 1.61% to 0.85 in 2025.
• The last three Equity Ratio figures came in at 0.85 (Q4 2025), 0.85 (Q3 2025), and 0.87 (Q2 2025), per Business Quant data.